Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Update

13 Jul 2016 07:00

RNS Number : 9966D
e2v technologies PLC
13 July 2016
 

13 July 2016

 

e2v technologies plc

AGM Update

 

e2v technologies plc today provides an update, ahead of today's AGM.

Overview

Activity in the first quarter, typically a quiet period for the Group, was muted. We expect to deliver a strong improvement in the second quarter, supported by order intake secured in June. Good operational progress is being made across the business and we will continue to take action on costs as appropriate. Cash collection has been in line and we have targeted inventory reductions to improve on our planned year end net debt reduction. Our outlook for the current financial year, subject to the broader economic environment, remains unchanged, with an H1/H2 revenue split of approximately 40:60.

Divisional update 

Imaging is arranged in two business streams: Professional Imaging and Space Imaging. Professional Imaging is seeing demand continuing to grow for industrial automation, particularly in Asia. Order intake across its activities increased in June for delivery in the second quarter and we have a good pipeline of opportunities which support the anticipated revenue profile for the remainder of the year. Space Imaging has good order cover in the short term. We are confident of securing the follow-on production orders where we are designed into major programmes. This underpins a significant step-up in revenue anticipated in the second half and builds the order book cover for the next financial year. Space Imaging is a long cycle business and continues to experience challenges on its technically demanding programmes.

RF Power is seeing improving demand in radiotherapy and continues to deliver to its OEM customers under the existing contracts, which are expected to be renewed before the year end. In commercial and industrial, we expect demand to remain steady. The defence business has the opportunity pipeline to support its anticipated revenue profile although we have seen some recent delays in programme awards.

In Semiconductors we achieved strong order intake in June for our component portfolio, and this supports the second quarter's revenue delivery. The anticipated revenue profile is expected to be supported by our partnership with Peregrine Semiconductors, product line acquisitions made in the prior year, NXP last time buy and SP Devices.

Financial position

Cash generation in the first quarter mainly reflected the expected collection of year end receivables, and net borrowings decreased by £11.2m to £9.9m (31 March 2016: £21.1m). We expect net borrowings at the half year to be broadly in line with the position as at 31 March 2016, reflecting the payment of dividends and tax.

We have increased our management team's ongoing focus on working capital management. We have reduced manufacturing cycle time in Space Imaging and we have made good progress with our reorganisation of the Chelmsford site. When completed within the next two years, it will provide further reductions in manufacturing cycle time and associated working capital. Semiconductors has implemented an inventory reduction plan, which is anticipated to deliver a reduction in inventory by the end of the financial year, and represents most of the incremental inventory improvement of £5m to enhance on our planned year end net debt reduction.

Over the next two years we see the opportunity for further reduction in working capital intensity by c.£10m coming from delivery of a more even revenue profile and further shortening of manufacturing cycle time.

Foreign Currency

A one cent strengthening in the US$ relative to Sterling is estimated to increase reported revenues by c.£1m with a c.40% drop through to adjusted operating profit. A one cent strengthening in the Euro relative to Sterling is estimated to increase reported revenue by c.£0.3m with a minimal drop through to profit given Euro denominated costs. We will provide an update on the possible effect of FX changes as the year progresses.

Interim results

The Group's next scheduled comment on trading will be the interim results announcement on 7 November 2016.

 

Further enquiries:e2v technologies plc

Steve Blair, Group CEO

Charles Hindson, Group Finance Director

 

Tel: +44 (0)1245 493 493

Website: www.e2v.com

FTI Consulting

Richard Mountain/Susanne Yule

Tel: +44 (0)20 3727 1340

Notes

1. e2v technologies plc is Bringing life to technology™. e2v partners with its customers to improve, save and protect people's lives. e2v's innovations lead developments in automation, healthcare, communications, safety, discovery and the environment..

2. All financial information included in this release is sourced from unaudited management accounts and excludes any specific items.

3. Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect the Group's current expectations concerning future events and actual results may differ materially from current expectations or historical results.

4. This announcement contains inside information regarding e2v technologies plc.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMRTMFTMBJBBIF
Date   Source Headline
3rd Jan 20144:37 pmRNSHolding(s) in Company
5th Dec 201311:42 amRNSAdditional Listing
27th Nov 201311:35 amRNSGeneral Meeting
19th Nov 20134:25 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
14th Nov 20133:27 pmRNSNotification of Major Interest in Shares
14th Nov 201312:49 pmRNSNotice of General Meeting
6th Nov 20134:57 pmRNSTransaction in Own Shares
4th Nov 201311:44 amRNSDirector/PDMR Shareholding
4th Nov 20137:00 amRNSHalf-year results for six months to 30 Sept 2013
18th Oct 20137:00 amRNSAppointment of Chief Executive
15th Oct 20137:00 amRNSPeriod end update
14th Oct 20134:15 pmRNSHolding(s) in Company
1st Oct 20134:51 pmRNSTransaction in Own Shares
27th Sep 20134:18 pmRNSPurchase of Own Shares
23rd Sep 20134:00 pmRNSShare buy-back programme
19th Aug 20132:15 pmRNSTotal Voting Rights
13th Aug 20134:15 pmRNSHolding(s) in Company
13th Aug 20131:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSDirector/PDMR Shareholding
19th Jul 20137:00 amRNSAwards under Long Term Incentive Plan
17th Jul 20131:45 pmRNSAnnual General Meeting 2013
17th Jul 20137:00 amRNSDirectorate Change
17th Jul 20137:00 amRNSInterim Management Statement
1st Jul 20134:35 pmRNSHolding(s) in Company
26th Jun 20134:29 pmRNSHolding(s) in Company
26th Jun 201311:11 amRNSHolding(s) in Company
12th Jun 201312:00 pmRNSDirectorate Change
20th May 20132:20 pmRNSDirector/PDMR Shareholding
20th May 20137:00 amRNSResults for the year ended 31 March 2013
25th Apr 20133:58 pmRNSNotification of Major Interest in Shares
22nd Apr 20135:00 pmRNSNotification of Major Interest in Shares
16th Apr 20137:00 amRNSTrading Statement
9th Apr 201310:00 amRNSTotal Voting Rights
18th Mar 20134:00 pmRNSNotification of Major Interest in Shares
18th Mar 20137:00 amRNSe2v wins ?10m ESA space science contract
6th Mar 20133:11 pmRNSHolding(s) in Company
6th Mar 20132:15 pmRNSHolding(s) in Company
5th Mar 20137:00 amRNSContract Renewal
22nd Feb 20132:02 pmRNSNotification of Major Interest in Shares
14th Feb 201311:00 amRNSDirector/PDMR Shareholding
12th Feb 20134:43 pmRNSDirector/PDMR Shareholding
12th Feb 201311:10 amRNSHolding(s) in Company
11th Feb 20134:13 pmRNSTotal Voting Rights
11th Feb 20137:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20137:00 amRNSInterim Management Statement
8th Jan 201311:40 amRNSTotal Voting Rights
7th Jan 20131:59 pmRNSDirector/PDMR Shareholding
7th Dec 20127:00 amRNSContract Renewal
3rd Dec 20127:00 amRNSSale of land
30th Nov 20123:39 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.